Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Introduction: Studies conducted in the pre-rituximab era found EBV positive diffuse large B-cell lymphoma (EBV+ DLBCL) as a disctinct entity carrying a dismal prognosis when compared with EBV negative (EBV-) DLBCL cases. However, studies evaluating this disparity in the rituximab era are lacking. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.1442-1442
Hauptverfasser:	Castro, Denisse, Beltran, Brady E, Villela, Luis, Montaño Figueroa, Efreen, Ramirez-Ibarguen, Ana Florencia, Candelaria, Myrna, Perini, Guilherme Fleury, Oliver, Ana Carolina, Martinez-Cordero, Humberto, Idrobo, Henry, Rios, Rosa Oliday, Valvert, Fabiola, Paredes, Sally Rose, Pellegrino, Carolina Cristina, Rodriguez, Yusaima, Lopez, Francisco, Irigoin, Victoria, De Galvez, Maria Gabriela, Castillo, Jorge J., Valcarcel, Bryan, Malpica Castillo, Luis
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!